Cases & Deals

  • Home
  • Practices
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma Plc

Share

Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma Plc

November 2018

Client(s) Huadong Medicine Co. Ltd.

Jones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million). HMC is a Chinese manufacturer and distributor of pharmaceutical and other medical products listed on the Shenzhen Stock Exchange with a market capitalization of approximately US$9.7 billion.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.